Shares outstanding increased 239.5%
Shares outstanding changed +239.5% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
7,504,780→25,478,1706 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BRTX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow decreased 37.0%
Operating cash flow changed -37.0% from the comparable as-filed period.
-$2.8M→-$3.8M3 prior comparisons
Operating income increased 29.6%
Operating income changed +29.6% from the comparable as-filed period.
-$4.8M→-$3.4M3 prior comparisons
Operating margin moved 461756 bp higher
Operating margin changed +461756 basis points from the comparable as-filed period.
-19230.14%→-14612.57%3 prior comparisons
Gross margin moved 2024 bp lower
Gross margin changed -2024 basis points from the comparable as-filed period.
88.36%→68.13%2 prior comparisons
Cash & equivalents increased 153.3%
Cash & equivalents changed +153.3% from the comparable as-filed period.
$1.2M→$3.1M3 prior comparisons
Total assets decreased 55.1%
Total assets changed -55.1% from the comparable as-filed period.
$10.3M→$4.6M3 prior comparisons
Working capital decreased 57.8%
Working capital changed -57.8% from the comparable as-filed period.
$5.2M→$2.2M3 prior comparisons
Current assets decreased 59.4%
Current assets changed -59.4% from the comparable as-filed period.
$9.4M→$3.8M3 prior comparisons
Current liabilities decreased 61.4%
Current liabilities changed -61.4% from the comparable as-filed period.
$4.2M→$1.6M3 prior comparisons
Trade receivables decreased 46.8%
Trade receivables changed -46.8% from the comparable as-filed period.
$25,000→$13,3003 prior comparisons
Stock-based compensation decreased 85.6%
Stock-based compensation changed -85.6% from the comparable as-filed period.
$2.0M→$290,2153 prior comparisons
Gross profit decreased 28.5%
Gross profit changed -28.5% from the comparable as-filed period.
$22,091→$15,7852 prior comparisons
SBC / revenue moved 678396 bp lower
SBC / revenue changed -678396 basis points from the comparable as-filed period.
8036.50%→1252.55%3 prior comparisons
Working capital / assets moved 301 bp lower
Working capital / assets changed -301 basis points from the comparable as-filed period.
50.10%→47.09%3 prior comparisons
Research & development increased 12.4%
Research & development changed +12.4% from the comparable as-filed period.
$1.7M→$1.9M3 prior comparisons
R&D / revenue moved 145651 bp higher
R&D / revenue changed +145651 basis points from the comparable as-filed period.
6857.31%→8313.82%3 prior comparisons
Operating cash-flow margin moved 531900 bp lower
Operating cash-flow margin changed -531900 basis points from the comparable as-filed period.
-11115.14%→-16434.15%3 prior comparisons
Receivables / revenue moved 4260 bp lower
Receivables / revenue changed -4260 basis points from the comparable as-filed period.
100.00%→57.40%3 prior comparisons
Revenue decreased 7.3%
Revenue changed -7.3% from the comparable as-filed period.
$25,000→$23,1703 prior comparisons
Current ratio increased 5.2%
Current ratio changed +5.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
2.24→2.353 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.